TrimRX
US$ 28.63
glp-1 receptor agonists for weight loss Comparing Ozempic, Wegovy and Other Drugs GLP-1 receptor agonists for individualized
Description
Protective effects of liraglutide on glomerular podocytes in obese mice by inhibiting the inflammatory factor TNF--mediated NF-B and MAPK pathway
Zweck E, Roden M
Although these results are highly promising, long-term data including primary CV prevention populations and utilizing other SGLT2-I will be needed to fully assess the CV outcomes with this class of medications
Emerging competitors are advancing differentiated mechanisms beyond single GLP-1 agonism
